Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: A Delphi Process and International Expert Panel

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Feb 15

PMID 35159946

Authors

Ana M Calinescu

Omid Madadi-Sanjani

Cara Mack

Richard A Schreiber

Riccardo Superina

Deirdre Kelly

Claus Petersen

Barbara E Wildhaber

Affiliations

Soon will be listed here.

Abstract

(1) Background: Acute cholangitis during the first year after Kasai hepatoportoenterostomy (HPE) has a negative impact on patient and native liver survival. There are no consistent guidelines for the definition, treatment, and prophylaxis of cholangitis after HPE. The aim of this study was to develop definition, treatment, and prophylaxis guidelines to allow for expeditious management and for standardization in reporting. (2) Methods: the Delphi method, an extensive literature review, iterative rounds of surveys, and expert panel discussions were used to establish definition, treatment, and prophylaxis guidelines for cholangitis in the first year after HPE. (3) Results: Eight elements (pooled into two groups: clinical and laboratory/imaging) were identified to define cholangitis after HPE. The final proposed definitions for suspected and confirmed cholangitis are a combination of one element, respectively, two elements from each group; furthermore, the finding of a positive blood culture was added to the definition of confirmed cholangitis. The durations for prophylaxis and treatment of suspected and confirmed cholangitis were uniformly agreed upon by the experts. (4) Conclusions: for the first time, an international consensus was found for guidelines for definition, treatment, and prophylaxis for cholangitis during the first year after Kasai HPE. Applicability will need further prospective multicentered studies.

Citing Articles

A comprehensive clinical and microbiological study on the diagnosis and management of cholangitis in patients with biliary atresia undergoing kasai portoenterostomy.

Aziz M, Abdullatif H, Soliman M, Okasha S, Nabil N, Balah M Indian J Gastroenterol. 2025; .

PMID: 40072834 DOI: 10.1007/s12664-024-01721-z.

"Post-Kasai Portoenterostomy Cholangitis: What Have We Learnt So Far?".

Samanta A, Sarma M J Clin Exp Hepatol. 2025; 15(3):102471.

PMID: 39816454 PMC: 11730534. DOI: 10.1016/j.jceh.2024.102471.

Biomarkers in biliary atresia - an elusive promise of predicting outcome.

Jagadisan B, Dhawan A Pediatr Res. 2025; .

PMID: 39774329 DOI: 10.1038/s41390-024-03772-6.

Comparison of surgical results and technical performance between robotic and laparoscopic approaches for Kasai portoenterostomy in biliary atresia: a multicenter retrospective study.

Zhang M, Tang J, Zheng Z, Zhang Y, Cao G, Li S Surg Endosc. 2024; 39(2):1128-1139.

PMID: 39702567 DOI: 10.1007/s00464-024-11452-z.

Comparison of different Kasai portoenterostomy techniques in the outcomes of biliary atresia: a systematic review and network meta-analysis.

Zhang Y, Liu S, Yang Q, Sun R, Liu J, Meng Y Pediatr Surg Int. 2024; 41(1):6.

PMID: 39592482 DOI: 10.1007/s00383-024-05920-9.

References

Webb N, Jiwane A, Ooi C, Nightinghale S, Adams S, Krishnan U . Clinical significance of liver histology on outcomes in biliary atresia. J Paediatr Child Health. 2016; 53(3):252-256. DOI: 10.1111/jpc.13371. View

Stringer M, Davison S, Rajwal S, McClean P . Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg. 2007; 42(8):1324-8. DOI: 10.1016/j.jpedsurg.2007.03.026. View

Parolini F, Boroni G, Milianti S, Tonegatti L, Armellini A, Garcia Magne M . Biliary atresia: 20-40-year follow-up with native liver in an Italian centre. J Pediatr Surg. 2018; 54(7):1440-1444. DOI: 10.1016/j.jpedsurg.2018.10.060. View

Lee J, Lim L, Quak S, Prabhakaran K, Aw M . Cholangitis in children with biliary atresia: health-care resource utilisation. J Paediatr Child Health. 2013; 50(3):196-201. DOI: 10.1111/jpc.12463. View

Tyraskis A, Davenport M . Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy. Pediatr Surg Int. 2015; 32(3):193-200. PMC: 4756036. DOI: 10.1007/s00383-015-3836-3. View

Chuang J, Lee S, Shieh C, Chen W, Chang N . Reappraisal of the role of the bilioenteric conduit in the pathogenesis of postoperative cholangitis. Pediatr Surg Int. 2000; 16(1-2):29-34. DOI: 10.1007/s003830050008. View

Goh L, Phua K, Low Y, Chiang L, Yong C, Chiou F . Analysis of Cholangitis Rates with Extended Perioperative Antibiotics and Adjuvant Corticosteroids in Biliary Atresia. Pediatr Gastroenterol Hepatol Nutr. 2021; 24(4):366-376. PMC: 8279824. DOI: 10.5223/pghn.2021.24.4.366. View

Wada M, Nakamura H, Koga H, Miyano G, Lane G, Okazaki T . Experience of treating biliary atresia with three types of portoenterostomy at a single institution: extended, modified Kasai, and laparoscopic modified Kasai. Pediatr Surg Int. 2014; 30(9):863-70. DOI: 10.1007/s00383-014-3551-5. View

Kelly D, Davenport M . Current management of biliary atresia. Arch Dis Child. 2007; 92(12):1132-5. PMC: 2066090. DOI: 10.1136/adc.2006.101451. View

10.

Qiao G, Li L, Cheng W, Zhang Z, Ge J, Wang C . Conditional probability of survival in patients with biliary atresia after Kasai portoenterostomy: a Chinese population-based study. J Pediatr Surg. 2015; 50(8):1310-5. DOI: 10.1016/j.jpedsurg.2015.03.062. View

11.

Chen S, Lin C, Tsan Y, Chan W, Wang J, Chou Y . Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy. BMC Pediatr. 2018; 18(1):119. PMC: 5880092. DOI: 10.1186/s12887-018-1074-2. View

12.

Wong K, Fan A, Lan L, Lin S, Tam P . Effective antibiotic regime for postoperative acute cholangitis in biliary atresia--an evolving scene. J Pediatr Surg. 2004; 39(12):1800-2. DOI: 10.1016/j.jpedsurg.2004.08.027. View

13.

Wada K, Takada T, Kawarada Y, Nimura Y, Miura F, Yoshida M . Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007; 14(1):52-8. PMC: 2784515. DOI: 10.1007/s00534-006-1156-7. View

14.

Luo Y, Zheng S . Current concept about postoperative cholangitis in biliary atresia. World J Pediatr. 2008; 4(1):14-9. DOI: 10.1007/s12519-008-0003-0. View

15.

Chen G, Liu J, Huang Y, Wu Y, Lu X, Dong R . Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia: a randomized controlled trial. Pediatr Surg Int. 2021; 37(8):1089-1097. DOI: 10.1007/s00383-021-04916-z. View

16.

Nio M, Wada M, Sasaki H, Tanaka H, Okamura A . Risk factors affecting late-presenting liver failure in adult patients with biliary atresia. J Pediatr Surg. 2012; 47(12):2179-83. DOI: 10.1016/j.jpedsurg.2012.09.003. View

17.

Ryon E, Parreco J, Sussman M, Quiroz H, Willobee B, Perez E . Drivers of Hospital Readmission and Early Liver Transplant after Kasai Portoenterostomy. J Surg Res. 2020; 256:48-55. DOI: 10.1016/j.jss.2020.06.019. View

18.

de Vries W, de Langen Z, Groen H, Scheenstra R, Peeters P, Hulscher J . Biliary atresia in the Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr. 2011; 160(4):638-644.e2. DOI: 10.1016/j.jpeds.2011.09.061. View

19.

Petersen C, Harder D, Melter M, Becker T, Wasielewski R, Leonhardt J . Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol. 2008; 103(3):712-9. DOI: 10.1111/j.1572-0241.2007.01721.x. View

20.

Ginstrom D, Hukkinen M, Kivisaari R, Pakarinen M . Biliary Atresia-associated Cholangitis: The Central Role and Effective Management of Bile Lakes. J Pediatr Gastroenterol Nutr. 2019; 68(4):488-494. DOI: 10.1097/MPG.0000000000002243. View